Alfred Mann

$1.50 B

Ranked #1250 in World

About Alfred Mann

Alfred E. Mann (1925-2016), an influential figure in the aerospace, biotechnology, and medical device industries, left an enduring mark with his innovative contributions. Born in Portland, Oregon, Mann founded Spectrolab and Heliotek, significant to aerospace advancements, later venturing into medical technologies with Pacesetter Systems, MiniMed, and Advanced Bionics among other companies, showing a consistent track record of successful enterprises. His philanthropic efforts included substantial donations to biomedical engineering through the Alfred E. Mann Institutes at prestigious universities. Mann's leadership as Chairman and CEO of MannKind Corporation, which gained FDA approval for Afrezza in 2014, underlines his commitment to advancing medical science. Remembered for his contributions to technology and philanthropy, Mann passed away in Las Vegas, leaving behind a legacy of innovation and generosity.

Born

November 06, 1925 in Portland, Oregon

Died

February 25, 2016 (aged 90)

Source Of Wealth

Medical Devices

Industries

Healthcare

Citizenship

United States

Education

Bachelor of Arts / Science, University of California, Los Angeles; Master of Science, University of California, Los Angeles

Spouse

Beverly Mann (divorced), Linda Mann (divorced), Susan Kendall Mann (divorced), Claude Mann (until death)

Children

Alfred E. Mann was born on March 26, 1925, in Portland, Oregon, to a Jewish family. His father, who hailed from England, worked as a grocer, while his mother, originally from Poland, was a talented pianist and singer.

Alfred Mann: Family

Mann was married four times throughout his life and had seven children.

Alfred Mann: Career Highlights

Mann's career was marked by a series of successful ventures in the medical technology industry. In 1956, he founded Spectrolab, a leading aerospace company that specialized in the production of solar cells for spacecraft. He also established Heliotek, a major supplier of solar cells for spacecraft. Both companies were sold to Textron in 1960, but Mann continued to manage them until 1972.

In the years that followed, Mann founded several other companies, including Pacesetter Systems, which focused on cardiac pacemakers and was later sold in 1985. He also established MiniMed, a company dedicated to insulin pumps, and Advanced Bionics, which specialized in neuroprosthetics.

At the time of his death, Mann was involved in several other companies, including Second Sight Medical Products (retinal prosthesis), Bioness (electrostimulation for neural defects), Quallion, LLC (high reliability batteries), and Stellar Microelectronics (electronic circuit manufacturer). He also served as the Chairman of the Southern California Biomedical Council (SCBC).

One of Mann's notable achievements was the development of an inhalable insulin (Afrezza) through MannKind Corporation, which received approval from the FDA in 2014. He served as the Chairman and CEO of MannKind Corporation and was a major investor in Eclipse Aviation and Mulholland Estates.

Alfred Mann: Companies

Spectrolab
Heliotek
Pacesetter Systems
MiniMed
Advanced Bionics
Second Sight Medical Products
Bioness
Quallion, LLC
Stellar Microelectronics
MannKind Corporation

Alfred Mann: Major Achievements

Founded several successful companies in the medical technology industry.
Developed an inhalable insulin (Afrezza) through MannKind Corporation.
Established the Alfred E. Mann Institutes for Biomedical Engineering at the University of Southern California, Purdue University, and the Technion.

Served as Life Trustee of the University of Southern California.

Alfred Mann: Awards & Achievements

Golden Plate Award of the American Academy of Achievement (2000)
Los Angeles Business Person of the Year by Business Journal (2003)
MDEA Lifetime Achievement Award (2011)

Alfred Mann: Personal Life & Legacy

Mann passed away on February 25, 2016, of natural causes in Las Vegas, Nevada, at the age of 90. He left behind a remarkable legacy as a successful entrepreneur, philanthropist, and visionary in the field of biomedical engineering.

Alfred Mann: Trivia

Mann attempted to make a donation to UCLA, but negotiations fell through due to disagreements over control over patents.
The Alfred E. Mann Institutes for Biomedical Engineering serve as business incubators for medical device development.
The Alfred Mann Foundation for Biomedical Engineering selects and oversees the institutes.

Wealth History

Timeline

1925

Alfred E. Mann is born in Portland, Oregon.

1956

Mann founds Spectrolab, a leading aerospace company.

1960

Mann sells Spectrolab and Heliotek to Textron but continues to manage them until 1972.

1985

Mann sells Pacesetter Systems, focused on cardiac pacemakers.

2000

Mann receives the Golden Plate Award of the American Academy of Achievement.

2003

Mann is named Los Angeles Business Person of the Year by Business Journal.

2011

Mann receives the MDEA Lifetime Achievement Award.

2014

MannKind Corporation's inhalable insulin (Afrezza) is approved by the FDA.

February 25, 2016

Alfred E. Mann dies of natural causes in Las Vegas, Nevada, at age 90.

Alfred Mann : FAQs

What is Alfred Mann's net worth?

As of 2015, Alfred Mann's net worth was $1.50 billion.

What are Alfred Mann's main sources of wealth?

Alfred Mann's main source of income comes from Medical Devices.

In which industry does Alfred Mann primarily operate?

Alfred Mann is primarily involved in the Healthcare industry.

What is Alfred Mann educational background?

Alfred Mann holds a Bachelor of Arts / Science from the University of California from Los Angeles and a Master of Science from the University of California from Los Angeles.

Is Alfred Mann dead?

Yes, Alfred Mann died on February 25, 2016 (aged 90).

How many children does Alfred Mann have?

Alfred Mann has 7 children.

Who was Alfred E. Mann and what are his major contributions to science and business?

Alfred E. Mann (1925-2016) was a pioneering entrepreneur and philanthropist, founding multiple companies including Spectrolab, Pacesetter Systems, MiniMed, Advanced Bionics, and MannKind Corporation. His contributions were primarily in the fields of aerospace, medical devices, and biotechnology, significantly impacting solar cell technology for spacecraft, cardiac pacemakers, insulin pumps, neuroprosthetics, and inhalable insulin.

What significant philanthropic efforts did Alfred E. Mann undertake in the field of biomedical engineering?

Alfred E. Mann made substantial philanthropic contributions to biomedical engineering through the establishment of the Alfred E. Mann Institutes for Biomedical Engineering at the University of Southern California, Purdue University, and Technion, investing hundreds of millions of dollars. These institutes aim to foster innovation in medical device development.

In what ways did Alfred E. Mann impact the aerospace and medical devices industry?

Alfred E. Mann profoundly impacted the aerospace industry by founding Spectrolab, a leading provider of solar cells for spacecraft. In the medical devices sector, he made significant strides with the founding of Pacesetter Systems for cardiac pacemakers, MiniMed for insulin pumps, and Advanced Bionics for neuroprosthetics, revolutionizing patient care and treatment options.

What recognitions did Alfred E. Mann receive for his contributions to technology and entrepreneurship?

Throughout his career, Alfred E. Mann was honored with numerous awards and recognitions, including the Golden Plate Award of the American Academy of Achievement in 2000, being named Los Angeles Business Person of the Year by Business Journal in 2003, and receiving the MDEA Lifetime Achievement Award in 2011, highlighting his significant contributions to technology, business, and entrepreneurship.